Bristol-Myers Squibb Says FDA-Approved ORENCIA Is Available For Adults With Moderate To Severe Rheumatoid Arthritis

By: via Benzinga
Bristol-Myers Squibb Company (NYSE: BMY) disclosed Wednesday the commercial launch of the FDA-approved ORENCIA ClickJectTM ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.